Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

Clinical trial NCT01215955 · COMPLETED

Trial details

NCT number: NCT01215955
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-12-01
Primary completion: 2013-01-01
Enrollment: 1117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.